Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DDAVP-associated hyponatremia.

K Delfanian, E T Zawada

    South Dakota Journal of Medicine
    |July 27, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Desmopressin acetate (DDAVP) effectively treats nocturnal enuresis in over half of patients, improving quality of life. However, serious side effects like hyponatremia can occur, especially in vulnerable populations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gitelman's syndrome: report of a 19-year old woman with intractable hypomagnesemia and hypokalemia, and a review of the syndrome.

    South Dakota journal of medicine·1999
    Same author

    Cure of Goodpasture's disease.

    South Dakota journal of medicine·1998
    Same author

    Nutcracker syndrome: an underdiagnosed cause for hematuria?

    South Dakota journal of medicine·1998
    Same author

    Evidence for distal tubular inhibition of calcium efflux by nisoldipine in the SHR rat.

    Experimental nephrology·1997
    Same author

    A case of 'reverse' pseudohyperkalemia.

    Mineral and electrolyte metabolism·1997
    Same author

    Cerebral vasculitis associated with acute post-streptococcal glomerulonephritis.

    American journal of nephrology·1997
    Same journal

    Idiopathic pure red cell aplasia: case report with review of literature.

    South Dakota journal of medicine·2006
    Same journal

    Acute immune thrombocytopenic purpura in children and adolescents in South Dakota 1998-2004.

    South Dakota journal of medicine·2006
    Same journal

    South Dakota pain surveys: results from 2001.

    South Dakota journal of medicine·2006
    Same journal

    Monteggia fractures: beware!

    South Dakota journal of medicine·2006
    Same journal

    Medical students learn policy and advocacy through annual Legislative Day.

    South Dakota journal of medicine·2006
    Same journal

    Education in end-of-life care: bridging disciplinary and institutional boundaries.

    South Dakota journal of medicine·2006
    See all related articles

    Area of Science:

    • Endocrinology
    • Pediatric Nephrology

    Background:

    • Desmopressin acetate (DDAVP) is a widely used treatment for nocturnal enuresis.
    • Over 250,000 patients in the US have been treated since 1989, with over half experiencing adequate control.

    Observation:

    • While generally safe, DDAVP is not without risks, particularly in elderly or very young patients.
    • Literature review and case studies identify risk factors for hyponatremia, including hepatic disease, surgery, stress, pain, renal issues, excessive fluid intake, and higher DDAVP doses.

    Findings:

    • The incidence of adverse effects from DDAVP for nocturnal enuresis is low.
    • Key risk factors for hyponatremia include hepatic disease, surgery, stress, pain, renal disorder, excessive fluid intake, and increased DDAVP dosage.

    Implications:

    Related Experiment Videos

    • Close monitoring of serum electrolytes and urine output is crucial.
    • Fluid restriction and avoiding low-sodium solutions can help prevent serious side effects like hyponatremia and seizures.